Breakthrough in Infectious Bronchitis Virus Vaccine Development Using Lipid Nanoparticles-mRNA

Strategic Insights -

Scientists at the South China Agricultural University have made significant progress in developing a vaccine against the infectious bronchitis virus (IBV), a highly contagious and economically devastating disease affecting the poultry industry worldwide. The research, funded by several prominent Chinese institutions, has resulted in the creation of lipid nanoparticles-mRNA that demonstrate immunogenic and protective properties against multiple IBV strains.

Key Takeaways:

  • The researchers designed five consensus sequence antigens against prevalent IBV strains using immunoinformatics methods and constructed four monovalent lipid nanoparticles-mRNA (GI-19, GI-13, GI-7, GVI-1) and one quadrivalent lipid nanoparticles-mRNA.
  • The safety and biodistribution of the lipid nanoparticles-mRNA were evaluated in SPF chickens, and the results showed that they induced a strong and durable immune response.
  • Infection assays with four genotypes of IBV strains revealed that immunization with a 10 μg dose of the lipid nanoparticles-mRNA provided complete protection for the chickens, while a 5 μg dose reduced disease severity, organ damage, and mortality, and inhibited viral replication and shedding.
  • The research indicates that these lipid nanoparticles-mRNA show great promise as a basis for IBV prevention and control and could be applied to the development of mRNA vaccines against other prevalent viruses.
  • The vaccine development is significant for the poultry industry, which experiences severe economic losses due to the lack of cross-protection among IBV genotypes.

Statistics:

  • The vaccine development involved the design of five consensus sequence antigens against prevalent IBV strains.
  • The researchers constructed four monovalent lipid nanoparticles-mRNA (GI-19, GI-13, GI-7, GVI-1) and one quadrivalent lipid nanoparticles-mRNA.
  • The safety and biodistribution of the lipid nanoparticles-mRNA were assessed in SPF chickens, resulting in a strong and durable immune response.
  • The vaccine provided complete protection against IBV in SPF chickens with a 10 μg dose.
  • A 5 μg dose of the vaccine reduced disease severity, organ damage, and mortality in SPF chickens.
  • The researchers inhibited viral replication and shedding in SPF chickens using the lipid nanoparticles-mRNA vaccine.

Sources:

  • NewsRx. Studies from South China Agricultural University in the Area of Infectious Bronchitis Virus Described (Lipid Nanoparticles-mrna Based On the Consensus Sequences of Avian Coronavirus S1 and N Genes Protect Animals Against Multiple Viral ...). Nanotechnology Weekly. September 22, 2025; p 668.
  • Chen, L., et al. "Lipid nanoparticles-mRNA based on the consensus sequences of avian coronavirus S1 and N genes protect animals against multiple viral infections." Journal of Nanobiotechnology, 2025; 23(1).